Clinical Trial Results:
A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Trial to Evaluate
the Efficacy and Safety of Saxagliptin in Combination with Metformin IR as Initial Therapy Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in
Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control.
Pharmacogenetics Blood Sample Amendment Number 01 - Site Specific
Summary
|
|
EudraCT number |
2006-000006-23 |
Trial protocol |
HU DE IT |
Global completion date |
01 May 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Jan 2017
|
First version publication date |
25 Jan 2017
|
Other versions |
|
Summary report(s) |
CV181-039 full data set |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.